Pacifica, CA, United States of America

Lidia Cristina Sambucetti


Average Co-Inventor Count = 7.0

ph-index = 3

Forward Citations = 173(Granted Patents)


Company Filing History:


Years Active: 2003-2006

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Journey of Lidia Cristina Sambucetti

Introduction

Lidia Cristina Sambucetti, an accomplished inventor based in Pacifica, California, has made significant contributions to the field of pharmaceuticals. With a total of three patents to her name, her work focuses on developing compounds with anti-proliferative properties, showcasing her commitment to advancing medical science.

Latest Patents

Lidia's recent patent involves the creation of hydroxamate compounds functioning as deacetylase inhibitors. These compounds have potential applications in pharmaceutical compositions, particularly in treating conditions characterized by abnormal cell proliferation. Her groundbreaking work in this area highlights the importance of innovation in medical research.

Career Highlights

Lidia currently works for Novartis AG, a leader in the pharmaceutical industry known for its dedication to improving global health. Throughout her career, she has focused on harnessing the power of chemistry to create solutions that address pressing health challenges, earning recognition for her innovative spirit and technical expertise.

Collaborations

Collaboration is vital in the world of innovation, and Lidia has had the privilege of working alongside esteemed colleagues such as Stacy W Remiszewski and Kenneth Walter Bair. Together, they combine their knowledge and skills to push the boundaries of pharmaceutical research, fostering an environment of creativity and discovery.

Conclusion

Lidia Cristina Sambucetti’s journey as an inventor exemplifies the impact of innovation in the pharmaceutical industry. With her unwavering dedication and collaborative efforts, she continues to pave the way for future advancements, making a lasting difference in the field of medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…